Literature DB >> 1656910

Malignant fibrous histiocytoma of the skin and the conjunctiva in xeroderma pigmentosum.

J Pe'er1, S Levinger, M Chirambo, N Ron, E Okon.   

Abstract

Patients with xeroderma pigmentosum (XP) experience cutaneous and ocular abnormalities, including neoplasia of epithelial and melanocytic cellular origin. Black patients with XP display more severe ocular abnormalities and neoplasia. We report the clinicopathologic findings in two black young children with XP who presented with malignant fibrous histiocytoma (one of the conjunctiva and the other one of the skin of the face). These appearances of malignant fibrous histiocytoma at an unusually early age and in rare locations are, to our knowledge, the first to be reported in XP and go along with the special characteristics of XP: frequent occurrence of tumors on exposed parts of the body at a very early age.

Entities:  

Mesh:

Year:  1991        PMID: 1656910

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

Review 1.  Management of fibrous histiocytoma of the corneoscleral limbus: report of a case and review of the literature.

Authors:  H Mietz; M Severin; G Arnold; B Kirchhof; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

2.  Atypical Fibroxanthoma of the Conjunctiva in Xeroderma Pigmentosum.

Authors:  Nabeel Shalabi; Anat Galor; Sander R Dubovy; Jordan Thompson; J Antonio Bermudez-Magner; Carol L Karp
Journal:  Ocul Oncol Pathol       Date:  2015-04-15

3.  Atypical fibroxanthoma: an unusual skin neoplasm in xeroderma pigmentosum.

Authors:  Ranjana Bandyopadhyay; Dipanwita Nag; Sanjay Bandyopadhyay; Swapan Kumar Sinha
Journal:  Indian J Dermatol       Date:  2012-09       Impact factor: 1.494

4.  Benign fibrous histiocytoma.

Authors:  Pushpa Varma; Shweta Walia; Raju Manglawat
Journal:  Indian J Ophthalmol       Date:  2014-04       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.